ScholarLens Back to search
2017•RMD OpenOpen access

Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis

Roy Fleischmann, Jahangir Alam, Vipin Arora, John Bradley, Douglas Schlichting, David Muram, Josef S Smolen

Open full text 54 citations

Abstract

Methods study design and patientsThe study design and patient inclusion/ exclusion criteria for each study have been described previously.9 10 Briefly, patients with ≥6/66 swollen and ≥6/68 tender joints and no prior bDMARD use were eligible.The presence of comorbidities that, in the opinion of the investigator, could constitute a risk when taking investigational product or could interfere with the interpretation of data

Open-access reader

About this research paper

What this paper is about

Methods study design and patientsThe study design and patient inclusion/ exclusion criteria for each study have been described previously.9 10 Briefly, patients with ≥6/66 swollen and ≥6/68 tender joints and no prior bDMARD use were eligible.The presence of comorbidities that, in the opinion of the investigator, could constitute a risk when taking investigational product or could interfere with the interpretation of data

Why it matters

OpenAlex reports 54 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Methods study design and patientsThe study design and patient inclusion/ exclusion criteria for each study have been described previously.9 10 Briefly, patients with ≥6/66 swollen and ≥6/68 tender joints and no prior bDMARD use were eligible.The presence of comorbidities that, in the opinion of the investigator, could constitute a risk when taking investigational product or could interfere with the interpretation of data

Key concepts: Medicine, Rheumatoid arthritis, Interpretation (philosophy), Physical therapy, Internal medicine, Intensive care medicine, Programming language, Computer science

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis — Research Paper | ScholarLens